Affiliation:
1. Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.
Abstract
Helicobacter pylori NCTC 11637, which is nonviable at pH 3.0, became viable after addition of 10 mM urea owing to ammonia production by urease. In a buffer supplemented with urea, ecabet sodium decreased both the production of ammonia and the number of viable cells of H. pylori NCTC 11637 and changed the bacteria from the bacilliform to the horseshoe or doughnut shape in a concentration-dependent manner. In particular, ecabet sodium (2 and 4 mg/ml) decreased the number of viable cells below the control level. Benzohydroxamic acid, a urease inhibitor, also caused a decrease in ammonia production accompanied by a decrease in the number of viable cells and changed the morphological form at pH 3.0, but the number of viable cells was not lowered below the control level. In buffers at various pHs without urea, ecabet sodium showed a concentration-dependent bactericidal effect on H. pylori at pHs 4.0 and 5.0 but not at pHs 6.0 and 7.0 while benzohydroxamic acid caused only a slight decrease in the number of viable cells at pH 4.0. These results suggest that ecabet sodium has strong bactericidal activity in addition to its urease-inhibiting activity under acidic conditions.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference34 articles.
1. Some micromethods for enzyme studies;Akamatsu S.;J. Biochem.,1952
2. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease;Bell G. D.;Q. J. Med.,1993
3. Bode G. P. Malfertheiner G. Lehnhardt and H. Ditschuneit. 1990. Virulence factors of Helicobacter pylori-ultrastructural features p. 63-73. In P. Malfertheiner and H. Ditschuneit (ed.) Helicobacter pylori gastritis and peptic ulcer. Springer-Verlag KG Berlin.
4. Polymorphisms bei Helicobacter pylori-Schlüsselfunktion für infektionsrezidive;Bode G.;Med. Klin.,1992
5. Optimal H. pylori (HP) therapy-a combination of omeprazole and triple therapy (TT);Borody T. J.;Gastroenterology,1994
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献